Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT) - Jacques, R M; Boonen, S; Cosman, F; Reid, I R; Bauer, D C; Black, D M; Eastell, R (J Bone Miner Res, 2012)